Latest Cash Flow News

Entertainment Rewards Ltd has issued a Target’s Statement recommending shareholders accept Suzerain Investment Holdings’ conditional off-market takeover offer at a significant premium. An independent expert concurs the offer is fair and reasonable, setting the stage for potential full ownership by Suzerain.

Vault Minerals has settled all its gold forward sales contracts for the second half of FY26 six months early, boosting its exposure to rising gold prices and reinforcing its shareholder value strategy.

Comms Group Limited reported a steady FY25 with revenue growth and a strong start to FY26, driven by the recent TasmaNet acquisition and expanding global contracts. The company is targeting over $75 million in annualised revenue and aims to boost EBITDA to $9-10 million.

Elixir Energy secures a $16.6 million capital raise led by Omega Oil and Gas, unlocking Phase-2 of its strategic plan to advance appraisal and production testing in Queensland’s Taroom Trough.

Elixir Energy secures $16.6 million in a capital raise led by Omega Oil and Gas, unlocking Phase-2 of its strategic plan to define reserves in Queensland’s Taroom Trough. This funding accelerates appraisal drilling and production testing, positioning Elixir for a pivotal year ahead.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

IVE Group Limited reported a robust FY25 with significant profit growth and margin expansion, driven by strategic logistics expansions and the rising Lasoo e-commerce platform. Despite a softer FY26 start, the company maintains steady dividends and growth ambitions.

High-Tech Metals Ltd has reported metallurgical test results from its Mt Fisher Gold Project confirming high gold recoveries of up to 92.8%, supporting near-term development plans and joint venture processing opportunities.

Solvar Limited has sold its New Zealand arrears loan book for NZ$8 million, accelerating its exit from the NZ market and announcing a special fully franked dividend for shareholders.

Barton Gold Holdings has completed its Phase 1 drilling at the Tunkillia Gold Project ahead of schedule and under budget, targeting the high-value S1 and S2 pits. The company anticipates strong cash flow and rapid payback from the S1 pit, with assay results expected soon.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.